OUTLOOK THERAPEUTICS, INC. Operating Income
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Operating Income of -$10.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.81M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$14.03M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$13.48M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$17.31M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for fiscal 2025 was -$67.06M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$71.70M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$53.13M.
- OUTLOOK THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$63.07M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.81M 10-Q · filed 2026-08-18 | -$24.84M derived: sum of 2 quarters · filed 2026-08-18 | -$38.32M 10-Q · filed 2026-08-18 | -$55.64M derived: sum of 4 quarters · filed 2026-08-18 | ||||
| 2026-03-31 | -$14.03M 10-Q · filed 2026-05-15 | -$27.51M 10-Q · filed 2026-05-15 | -$44.83M derived: sum of 3 quarters · filed 2026-05-15 | -$60.57M derived: sum of 4 quarters · filed 2026-08-18 | ||||
| 2025-12-31 | -$13.48M 10-Q · filed 2026-02-17 | -$30.80M derived: sum of 2 quarters · filed 2026-02-17 | -$46.55M derived: sum of 3 quarters · filed 2026-08-18 | -$58.94M derived: sum of 4 quarters · filed 2026-08-18 | ||||
| 2025-09-30 | -$17.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | -$33.06M derived: sum of 2 quarters · filed 2026-08-18 | -$45.45M derived: sum of 3 quarters · filed 2026-08-18 | -$67.06M 10-K · filed 2025-12-19 | ||||
| 2025-06-30 | -$15.75M 10-Q · filed 2026-08-18 | -$28.14M derived: sum of 2 quarters · filed 2026-08-18 | -$49.75M 10-Q · filed 2026-08-18 | -$72.62M derived: sum of 4 quarters · filed 2026-08-18 | ||||
| 2025-03-31 | -$12.39M 10-Q · filed 2026-05-15 | -$34.00M 10-Q · filed 2026-05-15 | -$56.88M derived: sum of 3 quarters · filed 2026-05-15 | -$76.44M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$21.61M 10-Q · filed 2026-02-17 | -$44.48M derived: sum of 2 quarters · filed 2026-02-17 | -$64.05M derived: sum of 3 quarters · filed 2026-02-17 | -$82.99M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | -$22.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | -$42.44M derived: sum of 2 quarters · filed 2025-12-19 | -$61.38M derived: sum of 3 quarters · filed 2025-12-19 | -$71.70M 10-K · filed 2025-12-19 | ||||
| 2024-06-30 | -$19.56M 10-Q · filed 2025-08-14 | -$38.50M derived: sum of 2 quarters · filed 2025-08-14 | -$48.83M 10-Q · filed 2025-08-14 | -$61.28M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$18.94M 10-Q · filed 2025-05-15 | -$29.26M 10-Q · filed 2025-05-15 | -$41.72M derived: sum of 3 quarters · filed 2025-05-15 | -$59.86M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$10.32M 10-Q · filed 2025-02-14 | -$22.78M derived: sum of 2 quarters · filed 2025-02-14 | -$40.92M derived: sum of 3 quarters · filed 2025-02-14 | -$47.76M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-09-30 | -$12.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | -$30.60M derived: sum of 2 quarters · filed 2024-12-27 | -$37.44M derived: sum of 3 quarters · filed 2024-12-27 | -$53.13M 10-K · filed 2024-12-27 | ||||
| 2023-06-30 | -$18.14M 10-Q · filed 2024-08-14 | -$24.98M derived: sum of 2 quarters · filed 2024-08-14 | -$40.67M 10-Q · filed 2024-08-14 | -$54.65M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$6.84M 10-Q · filed 2024-05-15 | -$22.53M 10-Q · filed 2024-05-15 | -$36.51M derived: sum of 3 quarters · filed 2024-05-15 | -$53.54M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$15.69M 10-Q · filed 2024-02-14 | -$29.68M derived: sum of 2 quarters · filed 2024-02-14 | -$46.70M derived: sum of 3 quarters · filed 2024-02-14 | -$65.61M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | -$13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-22 | -$31.01M derived: sum of 2 quarters · filed 2023-12-22 | -$49.92M derived: sum of 3 quarters · filed 2023-12-22 | -$63.07M 10-K · filed 2023-12-22 | ||||
| 2022-06-30 | -$17.02M 10-Q · filed 2023-08-14 | -$35.93M derived: sum of 2 quarters · filed 2023-08-14 | -$49.08M 10-Q · filed 2023-08-14 | -$62.52M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$18.91M 10-Q · filed 2023-05-15 | -$32.06M 10-Q · filed 2023-05-15 | -$45.49M derived: sum of 3 quarters · filed 2023-05-15 | -$56.97M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$13.15M 10-Q · filed 2023-02-14 | -$26.59M derived: sum of 2 quarters · filed 2023-02-14 | -$38.06M derived: sum of 3 quarters · filed 2023-02-14 | -$50.69M derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | -$13.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-29 | -$24.91M derived: sum of 2 quarters · filed 2022-12-29 | -$37.54M derived: sum of 3 quarters · filed 2022-12-29 | -$51.73M 10-K · filed 2022-12-29 | ||||
| 2021-06-30 | -$11.47M 10-Q · filed 2022-08-10 | -$24.10M derived: sum of 2 quarters · filed 2022-08-10 | -$38.29M 10-Q · filed 2022-08-10 | -$48.30M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | -$12.63M 10-Q · filed 2022-05-13 | -$26.82M 10-Q · filed 2022-05-13 | -$36.83M derived: sum of 3 quarters · filed 2022-05-13 | -$48.71M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$14.19M 10-Q · filed 2022-02-14 | -$24.20M derived: sum of 2 quarters · filed 2022-02-14 | -$36.08M derived: sum of 3 quarters · filed 2022-02-14 | -$42.85M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | -$21.89M derived: sum of 2 quarters · filed 2021-12-23 | -$28.66M derived: sum of 3 quarters · filed 2021-12-23 | -$36.84M 10-K · filed 2021-12-23 | ||||
| 2020-06-30 | -$11.88M 10-Q · filed 2021-08-13 | -$18.64M derived: sum of 2 quarters · filed 2021-08-13 | -$26.83M 10-Q · filed 2021-08-13 | -$39.52M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$6.76M 10-Q · filed 2021-05-14 | -$14.95M 10-Q · filed 2021-05-14 | -$27.64M derived: sum of 3 quarters · filed 2021-05-14 | -$33.28M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$8.18M 10-Q · filed 2021-02-16 | -$20.88M derived: sum of 2 quarters · filed 2021-02-16 | -$26.52M derived: sum of 3 quarters · filed 2021-02-16 | -$34.23M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | -$18.34M derived: sum of 2 quarters · filed 2020-12-23 | -$26.04M derived: sum of 3 quarters · filed 2020-12-23 | -$36.30M 10-K · filed 2020-12-23 | ||||
| 2019-06-30 | -$5.64M 10-Q · filed 2020-08-14 | -$13.35M derived: sum of 2 quarters · filed 2020-08-14 | -$23.61M 10-Q · filed 2020-08-14 | -$36.02M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$7.71M 10-Q · filed 2020-05-15 | -$17.96M 10-Q · filed 2020-05-15 | -$30.38M derived: sum of 3 quarters · filed 2020-05-15 | -$37.60M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$10.26M 10-Q · filed 2020-02-14 | -$22.67M derived: sum of 2 quarters · filed 2020-02-14 | -$29.89M derived: sum of 3 quarters · filed 2020-02-14 | -$36.72M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | -$12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | -$19.63M derived: sum of 2 quarters · filed 2019-12-19 | -$26.46M derived: sum of 3 quarters · filed 2019-12-19 | -$29.64M 10-K · filed 2019-12-19 | ||||
| 2018-06-30 | -$7.22M 10-Q · filed 2019-08-14 | -$14.05M derived: sum of 2 quarters · filed 2019-08-14 | -$17.23M 10-Q · filed 2019-08-14 | -$20.14M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$6.83M 10-Q · filed 2019-05-15 | -$10.01M 10-Q · filed 2019-05-15 | -$12.92M derived: sum of 3 quarters · filed 2019-05-15 | -$20.26M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$3.18M 10-Q · filed 2019-02-14 | -$6.09M derived: sum of 2 quarters · filed 2019-02-14 | -$13.43M derived: sum of 3 quarters · filed 2019-02-14 | -$21.26M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-09-30 | -$2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | -$10.25M derived: sum of 2 quarters · filed 2018-12-18 | -$18.09M derived: sum of 3 quarters · filed 2018-12-18 | -$35.88M 10-K · filed 2018-12-18 | ||||
| 2017-06-30 | -$7.34M 10-Q · filed 2018-08-14 | -$7.44M 10-Q · filed 2017-08-14 | -$15.17M derived: sum of 2 quarters · filed 2018-08-14 | -$32.97M 10-Q · filed 2018-08-14 | -$33.28M 10-Q · filed 2017-08-14 | -$42.92M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$7.84M 10-Q · filed 2018-05-15 | -$7.94M 10-Q · filed 2017-05-15 | -$25.63M 10-Q · filed 2018-05-15 | -$25.84M 10-Q · filed 2017-05-15 | -$35.59M derived: sum of 3 quarters · filed 2018-05-15 | -$57.61M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$17.80M 10-Q · filed 2018-02-14 | -$17.90M 10-Q · filed 2017-02-14 | -$27.75M derived: sum of 2 quarters · filed 2018-02-14 | -$49.78M derived: sum of 3 quarters · filed 2018-02-14 | -$52.73M derived: sum of 4 quarters · filed 2018-02-14 | |||
| 2016-09-30 | -$9.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | -$31.98M derived: sum of 2 quarters · filed 2017-12-29 | -$34.93M derived: sum of 3 quarters · filed 2017-12-29 | -$51.35M 10-K · filed 2017-12-29 | -$51.76M 10-K · filed 2016-12-29 | |||
| 2016-06-30 | -$22.03M 10-Q · filed 2017-08-14 | -$24.98M derived: sum of 2 quarters · filed 2017-08-14 | -$41.39M 10-Q · filed 2017-08-14 | -$58.77M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$2.95M 10-Q · filed 2017-05-15 | -$19.37M 10-Q · filed 2017-05-15 | -$36.74M derived: sum of 3 quarters · filed 2017-05-15 | -$47.78M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$16.41M 10-Q · filed 2017-02-14 | -$33.79M derived: sum of 2 quarters · filed 2017-02-14 | -$44.83M derived: sum of 3 quarters · filed 2017-02-14 | -$58.83M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | -$17.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | -$28.42M derived: sum of 2 quarters · filed 2016-12-29 | -$42.42M derived: sum of 3 quarters · filed 2016-12-29 | -$46.56M 10-K · filed 2016-12-29 | ||||
| 2015-06-30 | -$11.05M 10-Q · filed 2016-08-15 | -$25.05M derived: sum of 2 quarters · filed 2016-08-15 | -$29.19M 10-Q · filed 2016-08-15 | |||||
| 2015-03-31 | -$14.00M 10-Q · filed 2016-06-27 | -$18.14M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |